Oppenheimer Updates Recommended Israeli Stocks List
Oppenheimer’s Stock Recommendations Adjustments
Oppenheimer Asset Management has revised its list of recommended Israeli stocks, resulting in the removal of several companies, including Check Point, ICL, and CyberArk. CyberArk has been replaced in the list by Palo Alto Networks, which recently acquired the company. This adjustment reflects Oppenheimer’s analysis of market conditions and company performance.
New Additions to the Recommended List
Joining the updated list are several companies that Oppenheimer believes present future growth potential. These include:
- Novar: A manufacturer specializing in semiconductor production equipment.
- Cyber Intelligence Firm Cellebrite: Expected to see growth in contracts with the U.S. government.
- Audity: The owner of the makeup brand ILI Makeup, which is described as having “enormous potential and high risk” with its new brand.
Market Context and Expectations
Oppenheimer’s updates come in a backdrop of slow growth for the companies removed from the list. The company remains optimistic about the added stocks, particularly Cellebrite’s prospects within the U.S. government sector and Audity’s innovative approaches in the cosmetics market.
Related Business Developments
In related financial news:
- General Electric is set to receive a payment of 56 million shekels as part of its hydro storage project.
- The National Insurance Institute has extended its contract with a nursing company until the end of 2026.
- Danal has surged with a valuation of 371 million dollars after OPC acquired 30% of its flagship project in the U.S.
- Solarium shares have soared 30% following a successful development of a laser marker for the IDF.
In a broader context, these market adjustments illustrate the dynamics of Israeli companies in the stock market and the strategic re-evaluations by investment firms like Oppenheimer.
Meta Description: Oppenheimer updates its recommended Israeli stocks list, removing several slow-growing companies while adding new prospects like Cellebrite and Audity. Key developments in related businesses are also highlighted.
Tags: Oppenheimer, Israeli Stocks, Investment, Stock Market Update, Cellebrite, CyberArk, Audity, Novar, Investment Firms, Business News, Financial Development